{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:28:35Z","timestamp":1793132915318,"version":"4.5.0"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to develop and validate a preliminary classification and diagnostic model for rheumatoid arthritis-associated interstitial lung disease (RA-ILD) using routine, readily available clinical and laboratory parameters. Multiple machine learning algorithms were employed to construct a practical risk assessment tool suitable for use in primary hospital settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinical data were retrospectively collected. Patients were divided into RA and RA-ILD groups. After preprocessing, the cohort was randomly divided into training and validation sets. Variables demonstrating a trend toward significance on univariate analysis were subjected to LASSO regression, and feature variables were ultimately identified. Five machine learning models were constructed: CatBoost, logistic regression, support vector machine, decision tree, and random forest. Model performance was assessed on the validation set using accuracy, precision, recall, F1 score, and the area under the receiver operating characteristic (ROC) curve (AUC). The SHapley Additive exPlanations (SHAP) framework was used to identify key features and quantify their contributions to the optimal predictive model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 410 patients with RA were enrolled, among whom 100 (24.39%) were diagnosed with RA-ILD. 23 variables with a trend toward significance on univariate analysis were subjected to LASSO regression. Finally, seven features were selected for model construction: age, smoking history, LYMPH, LDH, RF, CA125, and CA199. Based on these features, five machine learning models were established for RA-ILD classification. In the validation set, the CatBoost model achieved the highest AUC of 0.784 (95% CI: 0.656\u20130.885) and the lowest Brier score of 0.158, demonstrating robust overall performance. The decision tree (DT) model exhibited comparable discriminatory ability, with an AUC of 0.783 (95% CI: 0.661\u20130.818), and attained the highest recall (0.653) and F1-score (0.603) across all models, reflecting strong classification efficacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Among the five evaluated models, CatBoost and DT models showed comparable and favorable overall performance for RA-ILD classification. SHAP analysis based on the CatBoost model identified CA199, CA125, and age as the most important contributors to model prediction. Both models hold promise for RA-ILD risk stratification in clinical practice, although further external validation is warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1807594","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T04:29:56Z","timestamp":1778732996000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["A machine learning-based classification model for interstitial lung disease in rheumatoid arthritis"],"prefix":"10.3389","volume":"13","author":[{"given":"Mingyao","family":"Li","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Immunology, Deyang People\u2019s Hospital, Deyang","place":["Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoli","family":"Wang","sequence":"additional","affiliation":[{"name":"Health Management Center, Deyang People\u2019s Hospital, Deyang","place":["Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"He","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Deyang People\u2019s Hospital, Deyang","place":["Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Deyang People\u2019s Hospital, Deyang","place":["Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Deyang People\u2019s Hospital, Deyang","place":["Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Deyang People\u2019s Hospital, Deyang","place":["Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Deyang People\u2019s Hospital, Deyang","place":["Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"837133","DOI":"10.3389\/fmed.2022.837133","article-title":"Interstitial Lung disease in rheumatoid arthritis: a practical review.","volume":"9","author":"Laria","year":"2022","journal-title":"Front Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1007\/s00296-017-3781-7","article-title":"Impact of interstitial lung disease on mortality of patients with rheumatoid arthritis.","volume":"37","author":"Kim","year":"2017","journal-title":"Rheumatol Int."},{"key":"B3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/rheumatology\/kes262","article-title":"A study of baseline prevalence and cumulative incidence of comorbidity and extra-articular manifestations in RA and their impact on outcome.","volume":"52","author":"Norton","year":"2013","journal-title":"Rheumatology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1136\/ard.56.10.596","article-title":"Pulmonary function tests and high resolution computed tomography of the lungs in patients with rheumatoid arthritis.","volume":"56","author":"Cortet","year":"1997","journal-title":"Ann Rheum Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00296-006-0234-0","article-title":"Radiological and functional assessment of pulmonary involvement in the rheumatoid arthritis patients.","volume":"27","author":"Kanat","year":"2007","journal-title":"Rheumatol Int."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/art.27405","article-title":"Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study.","volume":"62","author":"Bongartz","year":"2010","journal-title":"Arthritis Rheum."},{"key":"B7","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/BOR.0000000000000389","article-title":"Infections in rheumatoid arthritis.","volume":"29","author":"Atzeni","year":"2017","journal-title":"Curr Opin Rheumatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e17088","DOI":"10.1097\/MD.0000000000017088","article-title":"High-resolution computed tomography of the lung in patients with rheumatoid arthritis: prevalence of interstitial lung disease involvement and determinants of abnormalities.","volume":"98","author":"Salaffi","year":"2019","journal-title":"Medicine."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1161\/CIRCULATIONAHA.115.001593","article-title":"Machine learning in medicine.","volume":"132","author":"Deo","year":"2015","journal-title":"Circulation."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/j.ejim.2017.06.017","article-title":"The rise of artificial intelligence and the uncertain future for physicians.","volume":"48","author":"Krittanawong","year":"2018","journal-title":"Eur J Intern Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12968-019-0575-y","article-title":"Machine learning in cardiovascular magnetic resonance: basic concepts and applications.","volume":"21","author":"Leiner","year":"2019","journal-title":"J Cardiovasc Magn Reson."},{"key":"B12","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1136\/annrheumdis-2018-214354","article-title":"Machine learning identifies an immunological pattern associated with multiple juvenile idiopathic arthritis subtypes.","volume":"78","author":"Van Nieuwenhove","year":"2019","journal-title":"Ann Rheum Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1136\/ard-2022-223808","article-title":"Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes.","volume":"82","author":"Choi","year":"2023","journal-title":"Ann Rheum Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13075-022-02800-2","article-title":"Identification of biomarkers by machine learning classifiers to assist diagnose rheumatoid arthritis-associated interstitial lung disease.","volume":"24","author":"Qin","year":"2022","journal-title":"Arthritis Res Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s12890-025-03855-y","article-title":"A multi-biomarker machine learning approach for early prediction of interstitial lung disease in rheumatoid arthritis.","volume":"25","author":"Xu","year":"2025","journal-title":"BMC Pulm Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s10067-024-07282-y","article-title":"Development and validation of predictive factors influencing rheumatoid arthritis associated with interstitial lung disease.","volume":"44","author":"Zhou","year":"2025","journal-title":"Clin Rheumatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1002\/art.40574","article-title":"The lung in rheumatoid arthritis: focus on interstitial Lung disease.","volume":"70","author":"Spagnolo","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1007\/s00296-023-05313-6","article-title":"Four-factor risk score for the prediction of interstitial lung disease in rheumatoid arthritis.","volume":"43","author":"Koduri","year":"2023","journal-title":"Rheumatol Int."},{"key":"B19","doi-asserted-by":"publisher","first-page":"103056","DOI":"10.1016\/j.autrev.2022.103056","article-title":"Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease.","volume":"21","author":"Akiyama","year":"2022","journal-title":"Autoimmun Rev."},{"key":"B20","first-page":"587","article-title":"Tumour markers in rheumatoid arthritis-associated interstitial lung disease.","volume":"34","author":"Wang","year":"2016","journal-title":"Clin Exp Rheumatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s40744-021-00288-x","article-title":"Serum KL-6, CA19-9, CA125 and CEA are diagnostic biomarkers for rheumatoid arthritis-associated interstitial Lung disease in the chinese population.","volume":"8","author":"Zheng","year":"2021","journal-title":"Rheumatol Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/S2213-2600(17)30430-7","article-title":"An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study.","volume":"5","author":"Maher","year":"2017","journal-title":"Lancet Respir Med."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1807594\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T04:29:58Z","timestamp":1778732998000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1807594\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":22,"alternative-id":["10.3389\/fmed.2026.1807594"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1807594","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"article-number":"1807594"}}